Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications

• Elena González,

  Affiliation Department of Nephrology, La Paz University Hospital, IdiPAZ, FRIAT-IRSIN, REDinREN, Madrid, Spain

  ⨯
• Juan J. Díez,

  Affiliation Department of Endocrinology, University Hospital Ramón y Cajal, Madrid, Spain

  ⨯
• M. Auxiliadora Bajo,

  Affiliation Department of Nephrology, La Paz University Hospital, IdiPAZ, FRIAT-IRSIN, REDinREN, Madrid, Spain

  ⨯
• Gloria del Peso,

  Affiliation Department of Nephrology, La Paz University Hospital, IdiPAZ, FRIAT-IRSIN, REDinREN, Madrid, Spain

  ⨯
• Cristina Grande,

  Affiliation Department of Endocrinology, University Hospital Ramón y Cajal, Madrid, Spain

  ⨯
• Olaia Rodríguez,

  Affiliation Department of Biochemistry, La Paz University Hospital, IdiPAZ, FRIAT-IRSIN, REDinREN, Madrid, Spain

  ⨯
• Mariana Díaz-Almirón,

  Affiliation Biostatistics Section, La Paz University Hospital, IdiPAZ, FRIAT-IRSIN, REDinREN, Madrid, Spain

  ⨯
• Pedro Iglesias ,

  Contributed equally to this work with: Pedro Iglesias, Rafael Selgas

  * E-mail: piglo65@gmail.com

  Affiliation Department of Endocrinology, University Hospital Ramón y Cajal, Madrid, Spain

  ⨯
• Rafael Selgas

  Contributed equally to this work with: Pedro Iglesias, Rafael Selgas

  Affiliation Department of Nephrology, La Paz University Hospital, IdiPAZ, FRIAT-IRSIN, REDinREN, Madrid, Spain

  ⨯